Advances in detection and treatment for prostate cancer has improved so much that it's possible that patients are left with less dramatic side effects than those of past years. The key to this is early detection. Pranav Sharma, M.D., division chief of urologic oncology and clinical medical director, tells us who should get tested and when, who is at greater risk for prostate cancer and he explains what treatment is available and why sometimes not treating it is an option.
Advances in detection and treatment for prostate cancer has improved so much that it's possible that patients are left with less dramatic side effects than those of past years. The key to this is early detection. Pranav Sharma, M.D., division chief of urologic oncology and clinical medical director, tells us who should get tested and when, who is at greater risk for prostate cancer and he explains what treatment is available and why sometimes not treating it is an option.